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The association of inflammation with modern human
diseases (e.g. obesity, cardiovascular disease, type 2 dia-
betes mellitus, cancer) remains an unsolved mystery of
current biology and medicine. Inflammation is a protective
response to noxious stimuli that unavoidably occurs at
a cost to normal tissue function. This fundamental trade-
off between the cost and benefit of the inflammatory
response has been optimized over evolutionary time for
specific environmental conditions. Rapid change of the
human environment due to niche construction outpaces
genetic adaptation through natural selection, leading
increasingly to a mismatch between the modern environ-
ment and selected traits. Consequently, multiple trade-
offs that affect human physiology are not optimized to
the modern environment, leading to increased disease
susceptibility. Here we examine the inflammatory re-
sponse from an evolutionary perspective. We discuss
uniqueaspects of the inflammatory response and its evolu-
tionary history that can help explain the association
between inflammation and modern human diseases.
Introduction
Inflammation is classically described as a response to infec-
tion or injury. It is now increasingly appreciated that chronic
inflammation is universally associated with diseases of
affluence and extended lifespan such as obesity [1], cardio-
vascular [2] and neurodegenerative diseases [3], and cancer
[4]. The prevalence of these diseases has increased rapidly
over the past decades [5], raising two important questions—
what aspects of human biologymake us susceptible to these
diseases andwhy are diseases of disparate etiology all asso-
ciated with chronic inflammation?
The underlying reasons for the intimate association of
inflammation and disease are currently understood mainly
in the extreme cases when diseases are caused by a dysre-
gulated inflammatory response, such as inflammatory tissue
damage and sepsis [6,7]. Under these conditions, the nor-
mally protective role of inflammation becomes detrimental
when the response becomes excessive in magnitude or
duration. Anaphylaxis and septic shock are the two noto-
rious examples of excessive and potentially lethal inflamma-
tory responses. However, although excessive inflammation
can clearly be pathogenic, the near-universal association
of inflammation with human diseases cannot be explained
by dysregulation alone. The fundamental features of the
inflammatory process that contribute to disease suscepti-
bility are still poorly understood, as are the characteristics
of the target tissues and organs that make them vulnerable
to inflammatory pathologies.
Here we discuss inflammation and inflammatory diseases
from the evolutionary perspective. We focus on cost–benefit
trade-offs of the inflammatory response and discuss the
impact of our changing environment on human diseaseHHMI and Department of Immunobiology, Yale University Medical
School, New Haven, CT 06510, USA.
*E-mail: ruslan.medzhitov@yale.edususceptibility. Finally, we discuss inflammation in the
context of life history evolution.
Inflammation and Disease
An inflammatory response can be triggered by a variety of
noxious stimuli, including infection and injury. Accordingly,
the inflammatory responses are highly heterogeneous in
terms of the cell types and molecular mediators involved.
Inflammation also comes in different modalities that can be
classified as acute versus chronic and local versus systemic
[8]. Despite this complexity, all inflammatory responses can
be broken down into four common components that align
in a universal configuration of the inflammatory pathway:
inflammatory inducers, sensors, mediators, and target
tissues [9]. Inflammatory inducers can be exogenous signals
(e.g. pathogens and toxins [10]) or endogenous signals (e.g.
ATP or urate crystals [11]) that report on tissue stress, injury,
or malfunction [12]. Sensor cells, such as tissue-resident
macrophages and mast cells, detect inducers with specific
receptors and respond by producing inflammatory media-
tors. Depending on the nature of the inducers, sensor cells
produce different combinations and amounts of mediators,
creating a unique mediator signature for the inducer. Inflam-
matorymediators, in turn, act on target tissues and alter their
functional states, promoting elimination of the inducers,
adaptation to the noxious state, and restoration of tissue
homeostasis [9].
The alteration of target tissue functional states generally
occurs at the expense of the normal tissue function
[12–16], thus accounting for the fifth cardinal sign of inflam-
mation — functio laesa (‘disturbance of function’) [17]. This
fundamental property of inflammatory mediators underlies
the pathological potential of the inflammatory response.
Examples of inflammation-induced alteration in target tissue
functional states include: increased endothelial adhesive-
ness and permeability in response to the inflammatory
cytokines tumor necrosis factor a (TNFa) and interleukin-1
b (IL-1b), to allow exudate formation [6]; increased mucus
production by goblet cells in response to IL-13, to enhance
epithelial barrier defenses [18]; and synthesis and secretion
by hepatocytes of acute phase proteins (APPs) in response
to IL-6, to promote host defense from infection [19]. Each
of these effects provides an adaptive benefit in response
to infection; however, they come with a cost imposed by
a decline in the normal function of target tissues. In the above
examples, increased endothelial permeability and adhesive-
ness can impair hemostasis [20], increased mucus pro-
duction leads to mucus plug formation and reduced gas
exchange at respiratory epithelia [21,22], and increased
synthesis of APPs leads to a reduction in synthesis of
albumin and other serum proteins [19,23–25]. It is the alter-
ation of tissue and organ functional states that underlies
the pathological potential of the inflammatory response.
Importantly, because alteration of tissue functional states
is a fundamental consequence of any inflammatory
response, the cost and pathological potential of inflamma-
tion is present regardless of the magnitude and duration of
the response. Thus, while inflammatory tissue damage
caused by an excessive response is the most noticeable
negative outcome, it is not the only, and not even the most
common, cost of the inflammatory response.
Figure 1. Cost–benefit trade-offs are optimized to specific environ-
ments and can be affected by environmental change.
A particular trait can be selected and maintained by evolution as long
as the benefit of the trait outweighs the cost. Here the trait exists in
Environment 1 (Env1) with benefit B and cost C1. As the environment
changes, the cost of maintaining benefit B increases to C2. In all condi-
tions, the boundary of adaptive traits is defined by the line of cost %
benefit, where traits below and to the right of the line are considered
adaptive and traits above and to the left of the line are maladaptive.
However, there is an upper limit to the acceptable cost where the trait
becomes detrimental regardless of the benefit. These traits are defined
by a high absolute cost.
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a variety of homeostatic control mechanisms operated by
the endocrine and the nervous systems [21,26]. Hormones
and neurotransmitters regulate tissue and organ functional
activities to maintain key physiological variables, such as
blood pressure, blood glucose level, and core body temper-
ature, within a desired range around a characteristic set
point. Homeostatic control mechanisms also enable adapta-
tion to a changing environment or physiological needs [27].
For example, the autonomic nervous system controls
thermogenesis and heat dissipation to adapt to ambient
temperature and blood flow to the skeletal muscle and the
intestine depending on current priorities (hunting or escape
from predators versus food digestion) [28]. The pancreatic
hormones insulin and glucagon reciprocally control gluco-
neogenesis and glycogenolysis to regulate blood glucose
level in response to fasting and feeding [29]. Homeostatic
control mechanisms thus maintain and adjust the functional
states of tissues and organs according to stereotypical
changes in environmental conditions and predefined sets
of physiological priorities that are characteristic for a given
species in a given ecological niche.
However, when homeostasis is disrupted by noxious
conditions, including infection or tissue damage, homeo-
static control mechanisms are insufficient to maintain or
restore homeostasis. It is under these conditions that inflam-
matory control mechanisms are engaged in order to elimi-
nate the noxious stimulus and to restore homeostasis. In
order to perform these functions, inflammatory control
mechanisms alter the functional states of tissues and organs
in a way that is usually antagonistic to the homeostatic
control mechanisms. The reason for this is the difference
in the proximal objectives of homeostatic and inflammatorycontrols: the former aims to maintain the normal functional
state, while the latter aims to temporarily alter the functional
state in order to deal with the noxious stimulus or condition.
In addition to being antagonistic, inflammatory control
mechanisms are dominant over homeostatic controls [30].
The reason inflammatory control mechanisms can be
dominant over homeostatic controls is the higher priority
of the objectives of the former: the inflammatory response
is engaged by conditions that threaten an organism’s fitness
or even survival. For example, inflammatory mediators can
induce changes in core body temperature, appetite, sleep
patterns, nociceptive thresholds, vascular and airway
smooth muscle tone, and a variety of metabolic processes
[21]. These effects of inflammatory mediators are antago-
nistic to the homeostatic controls mediated by the hypo-
thalamus, autonomic nervous system, and endocrine
hormones. The changes in homeostatic parameters are
beneficial, since they aid the defense against noxious
insults, and costly, as they interfere with normal functions
regardless of the intensity or the duration of the inflamma-
tory response.
These characteristics account for the pathological poten-
tial of the inflammatory response and underlie a fundamental
cost–benefit trade-off inherent to inflammation — a point we
discuss in more detail next.
Cost–Benefit Trade-Offs and the Inflammatory Response
The trade-off between beneficial and detrimental aspects of
the inflammatory response has several characteristics that
may account for the rapid increase in inflammatory disease
prevalence in modern human populations. As these charac-
teristics are not unique to inflammation, wewill discuss them
from a more general perspective.
The cost–benefit trade-off of a given trait is optimized by
maximizing thebenefitwhileminimizing the cost. This optimi-
zation usually is specific for a particular environment: the trait
can be optimal in one environment and suboptimal or even
detrimental in other environments. Thus, changes to the rele-
vant aspects of the environment can alter the cost–benefit
balance, making it suboptimal and, at the extreme, maladap-
tive if the cost outweighs the benefit. If the environmental
change is stable, the trait can be either optimized to the
new environment through natural selection or lost altogether
if it negatively impacts reproductive fitness. The degree of
sensitivity to environmental factors can also vary for different
traits. Some traits, includingmany coremetabolic and devel-
opmental processes, are relatively independent of the envi-
ronment. Other traits, and their associated trade-offs, can
be highly sensitive to environmental change. These traits
tend to be ones that directly interface with the environment,
including immune and inflammatory responses, and would
be expected to be particularly sensitive to the relevant envi-
ronmental changes. Indeed, the cost–benefit trade-off of
the inflammatory response can be affected bymany environ-
mental factors, including altered exposure to commensal
and pathogenic microorganisms caused by high population
density, changes in diet and availability of hygiene products,
antibiotics, and vaccines. Because many of these environ-
mental factors changed dramatically in the past century,
one can expect that the cost–benefit trade-off of the inflam-
matory response in modern human populations is not opti-
mized to the current environment.
Generally, the benefit of a trait defines the acceptable cost:
as long as the benefit outweighs the cost the trait can be
Figure 2. Individual traits are characterized by cost–benefit ratios
(C/B).
C/B < 1 is required for a trait to be adaptive. However, cost–benefit
ratio is a function of the environment, and a given change in the envi-
ronmental factor can affect C/B of different traits to different degrees.
Here Trait1 is less sensitive than Trait2 to a given environmental
change. (A) In environment E, Trait1 has C/B1 and Trait2 has C/B2,
both of which are less than 1. (B) Environmental change, E’ / E’’,
causes a shift in the C/B ratio for both traits. Trait1 remains adaptive,
with C’’/B1 < 1, but Trait2 becomes maladaptive, with C’’/B2 > 1.
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a point: the cost can reach a physiological or evolutionary
limit (that is, affect survival or reproduction) when it becomes
unacceptable regardless of the associated benefit (Figure 1).
Within these limits, however, high-benefit traits (for example,
the traits that directly afford survival or reproductive
success) can be associated with high costs. Although in
a given environment the benefits of a trait are higher than
the costs, the traits differ in terms of the absolute values of
the costs and benefits: there are high-cost, high-benefit
traits and low-cost, low-benefit traits. Because a change of
the environment can alter the optimal cost–benefit balance,
the high-cost, high-benefit traits should generally be more
vulnerable to environmental change. Conversely, the traits
that have very low cost can be maintained as atavisms
even when the benefits once afforded by the trait are no
longer there. Non-adaptive traits can also be maintained
through sexual selection or through their association with
different beneficial traits. Therefore, all traits and their asso-
ciated trade-offs form a spectrum defined by their sensitivity
to changes in any given environmental factor (Figure 2).
Accordingly, a given change in the environment would affect
different trade-offs to different extents.
The inflammatory response is a high-cost, high-benefit
trait: high benefit because it can be life-saving in the face
of noxious challenges and high cost because inflammatory
defenses interfere with normal functions and, at the extreme,
can cause tissue damage and death. Therefore, the inflam-
matory response is particularly vulnerable to changes in
relevant environmental factors, a few examples of which
are changes in microbial exposure, diet, stress, toxins and
physical activity. This, in turn, likely contributes to the
dramatic increase in the prevalence of inflammatory
diseases that took place over the last few decades.
Direct Costs and Vulnerabilities
In considering the impact of cost–benefit balance on human
disease, it may be useful to distinguish between two types of
cost: direct costs and vulnerabilities. Direct costs are
unavoidable, recurring costs that are continuously accrued
as a result of deployment or maintenance of a trait. Vulnera-
bilities are rare but catastrophic consequences of a trait that
can be incurred by a fraction of a population. In terms of
cost–benefit balance, direct costs are optimized by reducing
their absolute value while vulnerabilities are optimized by
reducing their frequency or probability. Conversely, environ-
mental changes can increase either the value of direct costs
or increase the chances of experiencing the consequences
of vulnerabilities. However, the difference between direct
costs and vulnerabilities is not absolute: if vulnerabilities
become very common they can turn into direct costs.
To illustrate the differences between direct costs and
vulnerabilities, consider the analogy of car ownership.
Some direct costs associated with the benefit of owning
a car are the payments for the gasoline, insurance, and park-
ing. A vulnerability of having a car is the possibility of getting
into a fatal car crash. Both types of costs can increase or
decrease depending on both internal factors (engine effi-
ciency and car safety) and external factors (amount of traffic
and bad drivers). Furthermore, direct costs (high gasoline
and parking costs) or vulnerabilities (too many bad drivers)
can reach a point where they outweigh the benefit of owning
a car. Similarly, both direct costs and vulnerabilities of
biological traits can contribute to increased susceptibilityto human diseases in the face of suboptimal trade-offs
caused by changes in the environment. In the next section
we discuss several examples of human traits and their asso-
ciated disease susceptibilities.
Anatomical and Physiological Trade-Offs
A spectrum of common human diseases reflects, in part, the
direct costs and vulnerabilities of various traits of human
anatomy and physiology. Here we discuss four examples
that illustrate how trait-specific direct costs and vulnerabil-
ities impact the susceptibility to inflammatory diseases.
Additional examples of direct costs and vulnerabilities are
given in Table 1.
Exoskeleton and Endoskeleton
The exoskeleton and endoskeleton represent two different
solutions in the animal kingdom for mechanical support
and motility. The choice of a particular type of skeleton
Table 1. Trait-specific adaptive benefits, direct costs, and vulnerabilities.
Trait Adaptive benefit Direct cost Vulnerability
Epithelial regeneration Constantly replaces tissue, ensures
new and functional tissue available
at all times; tissue repair [21]
Metabolic costs of continuous
regeneration [21]
Slow accumulation of mutations
leading to development of cancer [69]
Oxygen metabolism Dramatic increase in energy
extraction [35]
Generation of reactive oxygen
species (ROS) [21]
Neurodegenerative disease, cellular
senescence [5,21,70]
Antioxidants
(e.g. uric acid)
Protect against ROS-mediated
damage [71]
Maintain serum urate through
production and renal resorption [72]
Antioxidant mechanisms predispose
humans to development of gout or
acute renal failure [37,38,41,42]
Endoskeleton Strong support system; removes
thickness to volume constraint on
size; increases types of movement [31]
Absence of exoskeleton-mediated
protection [31]
Fat embolism, osteoporosis,
osteopetrosis, fracture [5,21]
Synovial joints Increased freedom of motion [31] Wear and tear can lead to
osteoarthritis [33]
Development of inflammatory
arthritis [73]
Hemostasis Protects against trauma-induced
exsanguination [21]
Increased plasma viscosity places
increased demand on the
heart [46,47,74]
Inappropriate activation can lead to
sudden tissue ischemia; certain tissues
(e.g. brain and heart) are highly
susceptible to ischemia
Inflammation Restores homeostasis; clears infectious
pathogens [12]
Generation of ROS leads to
immunopathology and localized host
tissue damage [43]
Overwhelming, hyperactivation can
cause systemic inflammatory response
and lead to septic shock [45]
Adaptive immunity Allows for removal of pathogens in an
antigen-specific manner; allows for
memory of previous infections [8]
Maintenance of naı¨ve and memory
lymphocyte populations [8]
Inappropriate activation against self
antigen can lead to autoimmunity [8]
Microbiota Increased energy extraction from
environment; generation of specific
micronutrients humans are incapable
of producing [75]
Defense systems such as mucus barrier
and leukocyte presence are energetically
costly [76] and can impede systemic
nutrient absorption [77]
Inflammatory colitis [78] and recurrent
infections
Mucosal epithelia Protection from particulate matter and
infection [5,21]
Decreased diffusion and decreased
function [77]
Asthma and allergy [79]
Energy storage Ability to withstand short-term food
and nutrient insecurity [80]
Become an easy prey due to movement
limitation [80]
Loss of predation can lead to diabetes
or obesity [80]
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constraint on other evolutionary changes [31]. Animals with
exoskeletons are better protected from traumatic injury, at
the direct cost of constrained mobility, whereas animals
with endoskeletons enjoy increased mobility of body parts
but are more susceptible to injury (with the exception of
the brain where the skull effectively functions as an exoskel-
eton). Additionally, exoskeletons impose other constraints
on growth, heat dissipation, secretion, and gas exchange
that are not present in species with endoskeletons [32].
The increased freedom of movement in animals with an
endoskeleton is most pronounced at synovial joints [21].
These joints are distinguished by the presence of a synovial
cavity that contains a lubricating fluid as well as cartilage
plates on each articulating bone that function to absorb
shock and reduce friction.
Although synovial joints have numerous mechanical bene-
fits, they also present both direct costs and vulnerabilities.
A direct cost of this system is that persistent stress on the
joint leads to gradual erosion of articular cartilage, promoting
bone-on-bone friction and bone damage. Eventually the
persistent damage leads to both movement limitation and
movement-induced pain [21,33]. Thus, direct costs associ-
ated with the design of synovial joints make us susceptible
to osteoarthritis. The spatially confined structure of the
synovial joint makes it vulnerable to inflammatory exudate
formation. Unlike soft tissues that can withstand swelling
caused by an exudate, synovial joints are a confined space
where swelling in the joint is limited by the synovial
membrane. In addition, recruitment of leukocytes to the joint,
specifically macrophages and neutrophils, can create aself-sustaining inflammatory cycle that leads to progressive
joint dysfunction and destruction [6,7]. This condition —
rheumatoid arthritis — represents a vulnerability of the syno-
vial joints.
Oxidative Metabolism
Increased concentration of atmospheric oxygen drove the
evolution of oxidative metabolism, increasing energy extrac-
tion efficiency and allowing for the evolution of larger body
size [34–36]. One corollary (direct cost) of oxidative metabo-
lism is the elevated generation of reactive oxygen species
(ROS) that can cause tissue damage [21]. Potential ROS-
induced tissue damage drove the evolution of intracellular
and extracellular antioxidants that help mitigate the elevated
levels of ROS andmaintain tissue homeostasis. Primates are
unique in their extracellular antioxidant mechanisms,
utilizing urate and bilirubin as the two main plasma antioxi-
dants [37,38]. Elevated urate level in primates is the result
of an inactive form of the enzyme uricase that converts urate
to allantoin. Consequently, the plasma urate levels are 10-
fold higher in primates than in other animals, reaching the
limit of solubility at body temperature [39]. Interestingly,
the presence of inactive uricase is unique to primates and
parallels the loss in ability to synthesize another potent anti-
oxidant, ascorbic acid [40], suggesting a potential compen-
satory mechanism.
The presence of high plasma urate levels exposes
primates to unique vulnerabilities. Serum urate levels that
border on saturation create the potential for urate crystal
precipitation, particularly at places where temperature is
slightly lower than the core body temperature (e.g. joints of
Figure 3. Trade-off between life history characteristics is a function of
the environment.
(A) Favorable environment promotes investment of resources in
growth and reproduction while unfavorable environment promotes
somatic maintenance at the expense of growth and reproduction. (B)
Some aspects of unfavorable environment, such as infection or injury,
lead to an inflammatory response that in turn promotes somatic main-
tenance and inhibits pathways controlling growth and reproduction.
(C) Different environmental stresses activate different maintenance
programs to deal with that stress and inhibit maintenance programs
that are incompatible or linked by a functional or energetic trade-off.
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inflammasome complex, resulting in IL-1ß production and
the development of gout [41]. In addition, urate can pre-
cipitate in the kidney, leading to acute renal failure and
potentially death [42]. Taken together, high levels of urate
function as potent antioxidants but create vulnerabilities to
diseases. The propensity for urate crystallization is strongly
influenced by diet [5] and therefore this vulnerability should
be highly sensitive to environmental change (e.g. nutrient
composition).
Immune Response
Becausemicrobial infections can be life threatening, immune
defenses provide very high benefit and therefore the accept-
able costs can be very high as well (as discussed earlier).
The direct costs of the immune response include energetic
costs as well as collateral tissue damage. For example,
neutrophil-mediated anti-bacterial defense involves the
generation of very potent bactericidal ROS, such as hypo-
chlorite, superoxide, and hydrogen peroxide [43]. The gener-
ation of ROS is associated with host tissue damage [6]. This
is an unavoidable consequence of bacterial clearance, which
is partially mitigated by tissue-protective and wound-repair
mechanisms [44]. In addition to direct costs, the presence
of a rapid, overwhelming immune response creates a vulner-
ability manifested as systemic immune hyperactivation. This
vulnerability, known as septic shock, develops upon sys-
temic activation of the inflammatory response, leading to
a cascade of tissue and organ failures due to improper
tissue perfusion, disseminated intravascular coagulation,
and ultimately vascular collapse [45]. Autoimmune disease
is an example of vulnerability of the adaptive immune
system, and occurs when an immune response is directed
against an organism’s own antigens [8].
Blood Clotting
The coagulation cascade is another trait associated with
both direct costs and vulnerabilities. A closed circulatory
system has the benefit of highly efficient nutrient and oxygen
distribution. However, it creates a secondary problem of
maintaining hemostasis to ensure optimal vascular function
and to promote repair upon vascular damage. The compo-
nents of the clotting system are constitutively present in
the blood to ensure a rapid hemostatic response to damage.
Consequently, a direct cost of the clotting system is an
increase in plasma viscosity, which, in turn, increases strain
on the heart and necessitates increased resource investment
in heart function and size [46,47]. Fibrinogen is a key compo-
nent of the coagulation cascade and its concentration has
been linked to plasma viscosity and disease [48]. Vulnerabil-
ities of the clotting system are thrombosis, embolism,
ischemia and stroke, which can be caused by inappropriate
activation of the coagulation cascade [21].
Life History Trade-Offs
Life history traits are characteristics that directly affect repro-
ductive success and include age and size at maturity, repro-
ductive lifespan and aging, and number and size of offspring
[49]. Allocation of resources to any of these functions is
governed by a fitness trade-off and the allocation strategy
is specific to each organism–environment interaction. Life
history theory has shown that the balance of resource invest-
ment in these traits has been shaped by natural selection
to maximize an organism’s reproductive success [49].Resource investment in different life history traits is
dependent on the status of the environment. In general,
a favorable environment (e.g., abundant food, lack of preda-
tors, optimal temperature) promotes investment in growth
and/or reproduction while an unfavorable environment
promotes investment in maintenance programs (Figure 3A).
At the extremes, the maintenance programs can take forms
of suspended animation, such as hibernation, estivation,
diapause and dauer.
Human life history traits include relatively long lifespan,
large body size, delayed reproductive maturation, and low
fecundity with large parental investment in each offspring
[50]. One consequence of these life history traits is the
potential for environmental signals to influence resource
investment both in utero as well as during maturation. Given
that inflammation is a broad response to noxious conditions,
persistent inflammation may signal the presence of an
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favor somatic maintenance over growth and reproduction
(Figure 3B) [51]. Thus, the presence of a chronic inflamma-
tory response would be expected to affect life history traits
that can be interpreted under the rubric of direct costs
versus vulnerabilities.
Chronic colitis provides a good example of the effects
chronic inflammation can have on growth and maturation
given its onset during the time of maturation [21]. It has
been shown that colitis, including Crohn’s disease, is associ-
ated with growth retardation [52,53] and delayed pubertal
maturation [54,55] that is independent of nutrient absorption.
The reduced growth and pubertal maturation are correlated
with the elevated level of serum IL-6 and have been sug-
gested to be the consequence of IL-6-mediated suppression
of circulating insulin like growth factor-I (IGF-1) [56]. Further
evaluation of the effects of chronically elevated cytokines
was performed in mice that transgenically overexpress
IL-6. These mice were substantially smaller than genetically
identical non-transgenic animals [57] and females were
either infertile or had very small litters [58], further demon-
strating that inflammatory cytokines can alter life history
traits. In addition, inflammation can affect human reproduc-
tion during pregnancy, being a major contributor to pre-term
delivery, intrauterine growth restriction, pre-eclampsia and
spontaneous abortion [59,60]. Finally, in humans, pro-inflam-
matory cytokine production in response to infection has
been correlated with resistance to infection early in life but
inversely correlated with overall reproductive fitness [61].
Taken together, these findings suggest that inflammatory
mediators can ‘report’ on certain aspects of unfavorable
environment (such as abundance of pathogens) and directly
impact the life history traits of body size, age of reproduction,
and overall reproductive capacity. A prediction of this model
is that inflammation may promote somatic maintenance. It
should be noted, however, that, while all types of environ-
mental stress can promote somatic maintenance programs
at the expense of growth and reproduction, different
stresses induce different types of maintenance programs.
Furthermore, different maintenance programs can be either
compatible with or antagonistic to each other (Figure 3C).
For example, if two maintenance programs rely on the
same limited resource, they would be negatively correlated
or connected by a trade-off of their own. Therefore, inflam-
mation as a signal of environmental stress not only sup-
presses growth and reproduction during sensitive periods
but also can inhibit antagonistic maintenance programs,
such as those that control energy conservation. One simple
example of this concept is infection-induced sickness
behavior, which includes anorexia, fatigue and altered sleep
patterns [21]. While sickness behaviormay represent amain-
tenance program that promotes survival after infection [62],
it also compromises defenses against predation, including
the ‘fight or flight’ response.
Thus, from the life history perspective, inflammation may
compromise human health in two ways: first, by inhibiting
growth and reproduction programs, and second, by inter-
fering with incompatible maintenance programs.
Perspectives: Evolutionary Adaptations, Inflammation
and Diseases
The evolutionary perspective discussed above suggests that
several factors may contribute to the increased incidence of
inflammatory diseases.First, the cost–benefit trade-off of inflammatory defenses
has been optimized to an environment that no longer exists
for most human populations, particularly in industrialized
countries. Adaptation to the environment can occur by
several mechanisms, including genetic adaptation through
natural selection and non-genetic mechanisms of physiolog-
ical adaptation and phenotypic plasticity [63]. In addition,
some animals can alter the environment to various extents
to match their needs, a process known as niche construc-
tion [64]. Examples of human niche construction include
agriculture, Western diet, urban dwelling, and the use of
clothing, hygiene products, antibiotics and other medicines.
Humans rely on niche construction more than any other
organism, and this is responsible for the rapid, unprece-
dented change in our modern environment [65,66]. This
rapid change of multiple environmental factors caused by
niche construction in turn alters the optimal cost–benefit
balance of many traits, including the inflammatory response
(Figure 1). Consequently, the inflammatory processes can
be inappropriately engaged or dysregulated, causing the
disruption of homeostasis and promoting pathology,
including atopic and cardiovascular diseases, obesity and
type 2 diabetes.
Second, inflammation is a high-cost, high-benefit trait,
making it very vulnerable to the environmental changes
that can shift cost–benefit balances (Figure 2). Given the
high-cost nature of the inflammatory response, a suboptimal
cost–benefit balance has a high potential to negatively
impact fitness and cause disease. In addition, the benefits
of the inflammatory response tend to be manifested early
in life, when they have the highest impact on reproductive
fitness, while the ‘payment’ of the costs is often delayed until
the time when the organism is either going to die anyway
(due to high extrinsic mortality) or when the death or disease
will have little consequence for reproductive fitness. This
phenomenon of antagonistic pleiotropy [67,68] may be
particularly relevant to chronic inflammatory diseases, which
are often manifested at an advanced age. The increase
in human lifespan in industrialized countries is caused by
a reduction of extrinsic mortality and improved health care,
which in turn increased the fraction of the population that
experiences the negative impact of the traits that exhibit
antagonistic pleiotropy.
Third, direct costs and vulnerabilities of most traits of
human anatomy and physiology can negatively affect
homeostasis, particularly when these traits are not optimized
to a changing environment or exhibit antagonistic pleiotropy.
In the latter case, the value of direct costs and frequency
of vulnerabilities would increase with age. As these costs
increase, the disruption of homeostasis increases to the
point that it can no longer be controlled by homeostatic
control mechanisms, leading to the activation of inflamma-
tory control mechanisms. Thus, activation of inflammatory
control mechanisms leads to chronic inflammation, further
altering tissue functional states and creating a vicious circle
that converges on common inflammatory disease pheno-
types, including cardiovascular, metabolic, and neurode-
generative diseases. It should be noted in this context that
common inflammatory diseases are indeed diseases of dis-
rupted homeostasis. Thus, the costs of human anatomical
and physiological traits not only directly impact human
fitness, but also, by engaging inflammatory pathways, create
chronic inflammatory states that trigger, perpetuate or
exacerbate diseases of homeostasis.
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effect on life history traits. Inflammation is induced by
noxious environmental stimuli and therefore can signal an
unfavorable environment, a situation known to promote an
organism’s maintenance programs at the expense of growth
and reproduction. Thus, inflammation can cause certain
pathologies (growth stunting, spontaneous abortions)
because of the fundamental trade-off between the core life
history traits. In addition, inflammation can promote a
different class of diseases, such as metabolic diseases and
other diseases of homeostasis, due to the interference with
maintenance programs incompatible with inflammation.
In conclusion, an evolutionary perspective can provide
several insights into human susceptibility to inflammatory
diseases as well as the increased incidence of these
diseases in modern human populations. Ironically, improve-
ments in health care and reduced extrinsic mortality from
infections, starvation, and predation have created a new
set of vulnerabilities to diseases of affluence and old age.
This may be the biggest trade-off of them all.
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